TAIZHOU RUNDE offers a large selection of end feed Copper Fittings at the most competitive prices on the internet. These fittings are manufactured to EN1254-1 ,ASME B16.22 ,ASTM and ANSI standards from high purity, commercial grade C12200 alloy also used by leading copper manufacturers such as Mueller, Elkhart, Nibco and others. These copper pipe fittings are also NSF certified for use in potable water applications, Lead-Free compliant and UPC listed.end feed copper fittings,wrot joint copper fittings,EN1254-1 copper fittings,ASME B16.22 copper fittings end feed copper fittings,wrot joint copper fittings,EN1254-1 copper fittings,ASME B16.22 copper fittings Taizhou Runde Company , https://www.zjbrassfittings.com
The pharmaceutical trade surplus of 2.968 billion US dollars ranked first in raw material drugs
From January to June of this year, the total import and export of China's pharmaceutical products was US$ 13.654 billion, an increase of 49.67% year-on-year. Among them, the total amount of imports was US$5.343 billion, a year-on-year increase of 42.76%, a growth rate of 12.60 percentage points, and the total export value was US$8.311 billion, a year-on-year increase of 54.48%, a growth rate of 20.42 percentage points, and a trade surplus of US$2.968 billion.
Imports and exports of raw material drugs ranked first
Judging from the major categories of imports and exports of pharmaceutical commodities, in June, the total volume of imports and exports of chemical raw materials and medical devices was 4.669 billion U.S. dollars and 4.657 billion U.S. dollars, which were still the main components of import and export trade, and their market share reached 34.19% and 34.11%, which accounted for 68.30% of the total market share. Imports and exports of chemical raw materials and medical devices ranked first and second in terms of distinct advantages. The total import and export volume of Chinese patent medicines ranked third was US$1.422 billion. The proportion was 10.42%; followed by the total import and export of sanitary materials was 1.081 billion U.S. dollars, which slightly increased to 7.92%. The sum of chemical preparations, biological products, Chinese herbal medicines, and extracts is only 12.88 percentage points.
On the import side, from January to June, the import volume of medical equipment was 2.122 billion U.S. dollars, accounting for 39.73% of the total. The import volume of Chinese patent medicines was 1.186 billion U.S. dollars, accounting for 22.20%. The above share; imports of chemical agents amounted to US$817 million, accounting for 15.29%; imports of APIs amounted to US$738 million, accounting for 13.82%; and biological products, Chinese herbal medicines, extracts and other commodities were all less than 10%. Share.
On the export side, from January to June, chemical raw materials and medical devices accounted for half of the total export volume of pharmaceuticals from the major categories of imports and exports of pharmaceutical commodities. The export volume was 3.93 billion U.S. dollars and 2.534 billion U.S. dollars, respectively. In the major industries for foreign exchange earned through exports, the proportion of chemical raw materials was 47.29%, and the proportion of medical devices reached 30.49%. China's pharmaceutical export pharmaceutical raw materials and medical device pillar industries have occupied a dominant position; exports of sanitary materials accounted for 10.40%. The share of Chinese medicines and Chinese Herbal Pieces exports was 4.97%.
Import and export trade of raw material medicines showed a surplus
From January to June of 2008, the import and export of China's chemical raw materials was 4.669 billion U.S. dollars, an increase of 57.27% year-on-year, of which: the import amount was 738 million U.S. dollars, an increase of 42.72% year-on-year; the export amount was 3.930 billion U.S. dollars, an increase of 60.35 years. %, to achieve a trade surplus of 3.192 billion U.S. dollars. There are nearly 100 kinds of commodity classifications involving chemical raw materials, covering more than a thousand kinds of raw material products, such as cephalosporins, sulfonamides, VCs, pantothenic acid, calcium, sodium salts, and sulfates, but the product composition is difficult to change in the short term. The total export volume of vitamin C APIs still tops the list.
latest news
In the first 8 months of this year, vitamin exports doubled year-on-year
From January to August this year, the export volume of vitamin products was 113,600 tons, an increase of 16% year-on-year; the export amount was 1,537 million US dollars, an increase of 103% year-on-year, and it doubled. The reason is that the average export price rose by 75% year-on-year. Among them, vitamin E, vitamin B12, vitamin C, and vitamin A increased by 228%, 204%, 90%, and 81%, respectively.
The reason for the significant increase in the prices of vitamin products is that, in addition to the increase in market demand, we believe that there are both long-term and short-term factors that work together: The long-term factor is due to the increase in the cost of resource products such as coal, electricity, and natural gas, and the production of vitamins for corn. The sharp rise in the prices of major raw materials, the appreciation of the renminbi, and the increasingly tightening environmental protection policies in China have caused a substantial increase in costs and reduced profits, forcing producers to raise market prices; short-term factors are the impact of the Olympic Games on production and export products, and buyers are purchasing stocks in advance.
After the Olympics ended, the "post-Olympics" mentality filled the market, the market appeared to wait and see mood, some vitamin products prices will fall back.